New Billionaires Born Last Year19 new billionaires emerged in US AI startups... 70% of them in their 20s-30s Three years ...

The field of advanced manufacturing for high-performance materials in extreme environments is rapidly evolving, driven by the need for materials that can withstand harsh conditions such as high ...

June 2026 TIOBE Index shows Python slipping below 19%, C++ moving back ahead of Java, and Rust reaching #12 as Paul Jansen revises his plateau call.

Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 ...

ChatGPT Codex offers a unique way to simplify tasks and enhance productivity by interpreting plain English commands to perform a wide range of functions. In a walkthrough by AI Grid, beginners are ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Access to Algebra I is often shaped by uneven local practices. Placement can depend on ...

Apple showed off Siri AI demos at its annual WWDC keynote in Cupertino, Calif. Software SVP Craig Federighi and other execs discussed how Siri AI was built in a tech talk following the keynote. Apple ...

Getting faster doesn’t come from one single type of workout. Race-day speed is built by balancing different efforts the right way. Long runs lay the endurance foundation with slow, steady time on feet ...

Facing unprecedented stress on the traditional grid, PG&E is leveraging innovative advanced conductors and modernizing collateral infrastructure. Their flexible, adaptive framework guides deployment, ...

“USA250: The Story of the World’s Greatest Economy” is a yearlong WSJ series examining America’s first 250 years. Read more about it from Editor in Chief Emma Tucker. Imagine the first convincing ...

Tech expert ThioJoe uncovers malware so tricky even programmers fall for it. Why did Pakistan’s Asim Munir receive Iranians in military uniform but JD Vance in suit? Your eyes are warning you, 5 ...

April 10 (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Replimune's (REPL.O), opens new tab drug for advanced skin cancer, citing insufficient ‌data from studies, ...